Effect of tadarafil on lower urinary tract symptoms in patients treated with low dose rate brachytherapy for prostate cancer
Not Applicable
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000047981
- Lead Sponsor
- ara Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 220
Inclusion Criteria
Not provided
Exclusion Criteria
1 Patients who take nitric acid agents 2 Allergy to tadalafil 3 Unstable angina 4 Heart failure NYHA3 or more 5 Uncontrolled arrhythmia or hypotension 6 Myocardial infarction within 3 months 7 Cerebral infarction or hemorrhage within 6 months 8 Patients who take PDE 5 inhibitor 9 Ineligibility judged by the investigator due to medical, psychological or other reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method